Study identified plant-based compounds as potential HSP90 inhibitors in breast cancer, showing promising antiproliferative effects. Further research is needed to understand their mechanism of action for innovative therapeutic strategies.
Scientists studied the effects of extract on lipogenesis and tumorigenesis in triple-negative breast cancer (TNBC) by activating specific signaling pathways. This research may provide insights into potential management strategies for TNBC.
Scientists have found that an extract of Spatholobus suberectus Dunn (SSP), a medicinal plant, has broad-spectrum antiviral properties against SARS-CoV-1 and 2, HIV-1, and H5N1. SSP effectively inhibits viral entry, with EC values ranging from 3.6 to 5.1 μg/ml. Pre-treatment of pseudovirus or target cells with SSP showed consistent inhibitory activities with the respective EC value of 2.3 or 2.1 μg/ml. SSP blocked both SARS-CoV-2 spike glycoprotein and the host ACE2 receptor without toxic behavior. This plant extract has promising potential to be developed as a drug candidate for preventing and treating COVID-19 and other emerging enveloped viruses.
Researchers evaluated the neuroprotective effect of SS in rats with cerebral ischemia. The rats were divided into control, ischemia/reperfusion (I/R), and two groups treated with different doses of SS extract for 15 days before I/R. The results showed that SS significantly decreased oxidative stress and DNA damage and increased brain ATP levels and the expression of anti-inflammatory cytokines in the brain tissues of cerebral ischemic rats compared to I/R rats. The study suggests that SS has antioxidant, anti-apoptotic, and anti-inflammatory activity, making it a potential therapeutic agent for preventing neuronal damage from cerebral ischemia.